Search clinical trials for: Programmed Cell Death Ligand 1 (PD-L1)
Total 93747 results
-
Peking University Cancer Hospital & InstituteRecruitingUnresectable Hepatocellular CarcinomaChina
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCPoland, Taiwan, Thailand, Vietnam, United States, Korea, Republic of, Hungary, Russian Federation, Turkey, China, Australia, Netherlands
-
Olivia Newton-John Cancer Research InstituteAustin Health; Merck Healthcare KGaATerminated
-
Incyte CorporationCompletedHead and Neck Cancer | Gastric Cancer | Lung Cancer | Metastatic Cancer | Mesothelioma | Bladder Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer)Italy, Spain, United States, Netherlands
-
Peking University Cancer Hospital & InstituteRecruitingDigestive System CancersChina
-
Laekna LimitedRecruitingCervical Cancer | Esophageal Cancer | NSCLC | Solid Tumor | Endometrial Cancer | Gastric and Gastroesophageal Junction AdenocarcinomaChina
-
Beijing Friendship HospitalCompleted
-
AstraZenecaRecruiting
-
Hospital of Stomatology, Wuhan UniversityRecruitingClinical IVb Stage Oral Squamous Cell Carcinomas PatientsChina
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
Beijing Chest Hospital, Capital Medical UniversityNot yet recruitingLimited-stage Small-cell Lung Cancer
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingDiffuse Large B-Cell Lymphoma
-
Gradalis, Inc.WithdrawnLung Neoplasms | Advanced Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States
-
Fondazione Ricerca TraslazionaleUnknownCarcinoma, Non-Small-Cell Lung
-
Kartos Therapeutics, Inc.RecruitingMerkel Cell CarcinomaUnited States, Netherlands, Korea, Republic of, France, Germany, Spain, Canada, Italy, Australia, Brazil
-
NanoMab Technology (UK) LimitedKing's College London; Guy's and St Thomas' NHS Foundation TrustRecruiting
-
Hunan Cancer HospitalCompleted
-
Sinocelltech Ltd.UnknownHead and Neck Squamous Cell CarcinomaChina
-
Genentech, Inc.CompletedNeoplasmsUnited States, Spain, Belgium, Korea, Republic of, Canada, Australia, France
-
Groupe Hospitalier Pitie-SalpetriereInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedAutoimmune Diseases | Endocrine System Diseases | Cancer | Arthritis | Myositis | Neuropathy | Cardiac Disease | OphthalmopathyFrance
-
Eli Lilly and CompanyAstraZenecaCompletedHepatocellular Carcinoma | Gastric Cancer | Non-Small Cell Lung Cancer | Gastroesophageal Junction AdenocarcinomaUnited States, Spain, Korea, Republic of, Taiwan, Germany, Italy, France, Israel
-
The First Affiliated Hospital of Guangdong Pharmaceutical...University of Technology, Sydney; Guangzhou Anjie Biomedical Technology Co....UnknownNon-small Cell Lung Cancer | Lung Neoplasm MalignantChina
-
Guy's and St Thomas' NHS Foundation TrustNanoMab Technology (UK) LimitedRecruitingMelanoma | Non-small Cell Lung CancerUnited Kingdom
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Capital Medical UniversityDuke UniversityCompleted
-
Capital Medical UniversityDuke University; Geneplus-Beijing Co. Ltd.CompletedNeoplasms | Lung CancerChina
-
Johannes Gutenberg University MainzMerck KGaA, Darmstadt, GermanyCompleted
-
Shandong New Time Pharmaceutical Co., LTDNot yet recruiting
-
University of Colorado, DenverCancer League of ColoradoWithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | PD-L1 Gene MutationUnited States
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Not yet recruitingAdvanced Solid TumorsChina
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Belgium, Hong Kong, Italy, Slovenia, Australia, Canada, Bulgaria, Germany, France, Georgia, Singapore, Spain, Bosnia and Herzegovina, Switzerland, Turkey, Japan, United Kingdom, Netherlands
-
National Cancer Institute (NCI)Recruiting
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingGlioblastoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Triple Negative Breast Cancer | Biliary Tract CancersUnited States, Argentina, Australia, Canada, Chile, Colombia, France, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Tongji UniversityRecruitingA Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver MutationsNSCLC, Stage IIIA | EGF-R Negative Non-Small Cell Lung Cancer | ALK Negative NSCLCChina
-
Incyte CorporationCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingAdvanced Malignant Skin Neoplasm | Metastatic Malignant Skin NeoplasmUnited States
-
Grand Hôpital de CharleroiCliniques universitaires Saint-Luc- Université Catholique de LouvainActive, not recruiting
-
Second Military Medical UniversityUnknownAdvanced Hepatocellular CarcinomaChina
-
Institute of Oncology LjubljanaUniversity of Ljubljana; Military Medical Academy, Belgrade, SerbiaRecruitingMetastatic Melanoma | Immune Checkpoints Inhibitors | Gastrointestinal Microbiome (Bacterial and Viral) | Exosomal mRNA Expression of PD-L1 and IFNγSlovenia
-
Shanghai Chest HospitalNot yet recruitingEsophageal CancerChina
-
Women's Hospital School Of Medicine Zhejiang UniversityNot yet recruiting
-
Huabo Biopharm Co., Ltd.RecruitingTumor, SubjectsUnited States, China
-
Sichuan UniversityInnovent Biologics (Suzhou) Co. Ltd.Completed
-
M.D. Anderson Cancer CenterRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Clinical Stage III Cutaneous Melanoma AJCC v8 and other conditionsUnited States
-
Nabil AdraGenentech, Inc.; Indiana University School of MedicineTerminated
-
RWJ Barnabas Health at Jersey City Medical CenterUnknown
-
King Faisal Specialist Hospital & Research CenterAstraZenecaCompleted
-
Lei LiRecruitingEpithelial Ovarian Cancer | Microsatellite Instability | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Peking University People's HospitalUnknown
-
Melanoma and Skin Cancer Trials LimitedRecruitingNeuroendocrine Tumors | Merkel Cell Carcinoma | Merkel Cell Carcinoma, Stage I | Merkel Cell Carcinoma, Stage II | Merkel Cell Carcinoma, Stage III | Carcinoma Neuroendocrine SkinAustralia, New Zealand